Search Results
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain
Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
NETs is the carcinoid syndrome (CS). First described in 1931 ( Scholte 1931 ), this syndrome is characterized by the occurrence of increased bowel movements, vasoactive flushes and bronchospasms as well as long-term fibrotic changes in the mesentery and
Search for other papers by Yu-fang Bi in
Google Scholar
PubMed
Search for other papers by Rui-xin Liu in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Hai Fang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, State Key Laboratory of Medical Genomics, Department of Thoracic Surgery, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases
Search for other papers by Xiao-ying Li in
Google Scholar
PubMed
Search for other papers by Wei-qing Wang in
Google Scholar
PubMed
Search for other papers by Ji Zhang in
Google Scholar
PubMed
Search for other papers by Kan-Kan Wang in
Google Scholar
PubMed
Search for other papers by Lei Jiang in
Google Scholar
PubMed
Search for other papers by Ting-wei Su in
Google Scholar
PubMed
Search for other papers by Zhong-yuan Chen in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, State Key Laboratory of Medical Genomics, Department of Thoracic Surgery, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases
Search for other papers by Guang Ning in
Google Scholar
PubMed
adenocarcinomas. Carcinoid tumors derived from the thymus were first documented in 1972 ( Rosai & Higa 1972 ). It can be associated with ectopic ACTH syndrome or may be a component of multiple endocrine neoplasia syndrome type 1 (MEN1). Most carcinoids are benign
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Search for other papers by Thomas O'Dorisio in
Google Scholar
PubMed
Search for other papers by Alexandria Phan in
Google Scholar
PubMed
Search for other papers by Emily Bergsland in
Google Scholar
PubMed
Search for other papers by Linda Law in
Google Scholar
PubMed
Search for other papers by Phillip Banks in
Google Scholar
PubMed
Search for other papers by Joel Freiman in
Google Scholar
PubMed
Search for other papers by Kenny Frazier in
Google Scholar
PubMed
Search for other papers by Jessica Jackson in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Larry Kvols in
Google Scholar
PubMed
Search for other papers by Pablo Lapuerta in
Google Scholar
PubMed
Search for other papers by Brian Zambrowicz in
Google Scholar
PubMed
Search for other papers by Douglas Fleming in
Google Scholar
PubMed
Search for other papers by Arthur Sands in
Google Scholar
PubMed
Introduction Carcinoid syndrome is characterized by watery diarrhea, episodic flushing, bronchoconstriction, and eventually, the development of right-sided valvular heart disease. The symptoms of carcinoid syndrome have been attributed, in part, to
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Search for other papers by David J Gross in
Google Scholar
PubMed
Department of Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for other papers by Marta Benavent in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Raj Srirajaskanthan in
Google Scholar
PubMed
Search for other papers by Richard R P Warner in
Google Scholar
PubMed
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Search for other papers by Lowell B Anthony in
Google Scholar
PubMed
Search for other papers by Pamela L Kunz in
Google Scholar
PubMed
Search for other papers by Dieter Hörsch in
Google Scholar
PubMed
Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Search for other papers by Pablo Lapuerta in
Google Scholar
PubMed
Search for other papers by Wenjun Jiang in
Google Scholar
PubMed
Search for other papers by Kenneth Kassler-Taub in
Google Scholar
PubMed
Search for other papers by Suman Wason in
Google Scholar
PubMed
Search for other papers by Rosanna Fleming in
Google Scholar
PubMed
Search for other papers by Douglas Fleming in
Google Scholar
PubMed
Search for other papers by Rocio Garcia-Carbonero in
Google Scholar
PubMed
Introduction Carcinoid syndrome (CS) is a disorder that develops in up to 20% of patients with neuroendocrine tumors (NETs) and is characterized by severe diarrhea, flushing, abdominal pain, and eventually cardiac valvular complications, which
Department of Cardiology, Department of Obesity and Endocrinology, Clinical Sciences Centre, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK
Search for other papers by Rebecca Dobson in
Google Scholar
PubMed
Search for other papers by Daniel J Cuthbertson in
Google Scholar
PubMed
Search for other papers by Malcolm I Burgess in
Google Scholar
PubMed
Introduction Neuroendocrine tumours (NETs) are a varied group of tumours that arise from neuroendocrine precursor cells. They are rare occurring in 1.2–2.1/100 000 of the general population ( Modlin & Sandor 1997 ). Carcinoid syndrome, which is
Search for other papers by Larry K Kvols in
Google Scholar
PubMed
Search for other papers by Kjell E Oberg in
Google Scholar
PubMed
Search for other papers by Thomas M O'Dorisio in
Google Scholar
PubMed
Search for other papers by Pharis Mohideen in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Rudolf Arnold in
Google Scholar
PubMed
Search for other papers by Ke Hu in
Google Scholar
PubMed
Search for other papers by Yilong Zhang in
Google Scholar
PubMed
Search for other papers by Gareth Hughes in
Google Scholar
PubMed
Search for other papers by Lowell Anthony in
Google Scholar
PubMed
Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
these amines and peptide hormones, especially serotonin and substance P, is responsible for the principal symptoms of diarrhea and flushing associated with carcinoid syndrome. Surgery is essential in the management of metastatic NETs and can be curative
Search for other papers by Anela Blažević in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
of the ability of EC cells to secrete amines and peptides can cause distinct hormonal syndromes in SI-NETs ( de Herder 2005 , Yao et al . 2008 ). Carcinoid syndrome, marked by diarrhoea and flushing, is the most established of these hormonal
Search for other papers by Katarina Edfeldt in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Göran Åkerström in
Google Scholar
PubMed
Search for other papers by Gunnar Westin in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
( Schnirer et al . 2003 ). The tumors are neoplasms of peptide- and amine-producing cells. Some patients will develop the carcinoid syndrome due to excessive secretion of serotonin and other metabolites, which includes flushing, diarrhea, abdominal pain
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Yu-cheng Wang in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Marlene B Zuraek in
Google Scholar
PubMed
Search for other papers by Yasuhiro Kosaka in
Google Scholar
PubMed
Search for other papers by Yasuharu Ota in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Michael S German in
Google Scholar
PubMed
Search for other papers by Evan S Deneris in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Emily K Bergsland in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by David B Donner in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Robert S Warren in
Google Scholar
PubMed
UCSF Helen Diller Family Comprehensive Cancer Center, Department of Surgery, Hormone Research Institute, Department of Medicine, Department of Neurosciences, Diabetes Center
Search for other papers by Eric K Nakakura in
Google Scholar
PubMed
heart disease (i.e. carcinoid syndrome; Ishizuka et al . 1992 , von Wichert et al . 2000 ). Current therapy has limited efficacy in shrinking tumors and is ineffective in palliating symptoms in the long term ( Nakakura et al . 2007 ). Earlier
Search for other papers by Kjell Öberg in
Google Scholar
PubMed
Search for other papers by Steven W J Lamberts in
Google Scholar
PubMed
). Non-functioning endocrine tumours do not secrete measurable amounts of biologically active hormones; in contrast, hormone hypersecretion from functioning GEP-NET is responsible for causing distinct clinical syndromes. Carcinoid syndrome is